MACOM MTSI Gains Analyst Confidence as AI Inference Shift Drives Semiconductor Demand Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Amid Incoming Chair Warshs Dilemma Trump Tariffs Harming US Manufacturers Supply Chain Costs Rise Understanding Debt Settlement How It Works and Potential Costs LRS Outflows Surge 109 in March as Equity Investments and Foreign Deposits Rebound Britains Energy Shock MiniMeasures Seen as Insufficient Amid Iran Conflict Concerns CR Q1 2026 Earnings Strong EPS Beat Despite Modest Stock Reaction SOJF Q1 2026 Earnings Earnings Beat Expectations with 591 Surprise IRM Q1 2026 Earnings Strong EPS Beat Highlights Resilient REIT Performance Interlink Electronics Q3 2025 Earnings NarrowerThanExpected Loss Drives Modest Stock Gain EBMT Q1 2026 Earnings EPS Surpasses Estimates by 769 in Modest Beat XWEL Q3 2023 Earnings Significant EPS Miss with No Reported Revenue Core Scientific CORZ Gains 177 as Cryptocurrency Mining Sector Shows Renewed Momentum Wolfspeed WOLF Edges Higher Amid Consolidation Key Support and Resistance Levels to Watch John Hancock Preferred Income Fund HPI Holds Steady Near 1606 as Key Support and Resistance Levels Define Potential Path BGM Group Ltd BGM Edges Higher Amid Light Trading Key Levels to Watch Gesher Acquisition Corp II Warrants Hold Steady at 022 as Trading Range Tightens SpaceX IPO What Investors Should Know About the Upcoming Public Offering ODFL Q1 2026 Earnings EPS Surpasses Estimates Amid Steady Operations Core Scientific Warrants CORZW Climb 216 as Bitcoin Mining Sector Finds Footing SailPoint Q1 2026 Earnings Slight EPS Miss Positive Market Reaction CGBD Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance AFLAC Q1 2026 Earnings EPS Misses Estimates Amid Operating Challenges NNOX Q4 2025 Earnings WiderThanExpected Loss as Revenue Details Remain Scarce MBINL Q1 2026 Earnings Preferred Shares Beat EPS Estimates as Earnings Surprise Exceeds 5 BRT Q1 2026 Earnings Beats EPS Estimates Despite Negative Earnings ADXN Q1 2024 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances